跳至主要内容
临床试验/CTRI/2012/06/002741
CTRI/2012/06/002741已完成2 期

Phase II study of Interim PET-CT scan-guided response adapted therapy in Hodgkinâ??s Lymphoma

Cancer Institute0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed patients of Advanced Hodgkins lymphoma- stages IIB, III and IV

排除标准

  • Pregnancy, Lactating Mothers

研究者

发起方
Cancer Institute

相似试验

进行中(未招募)
1 期
Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancer
EUCTR2016-002360-14-DKRigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET90
进行中(未招募)
1 期
uPAR PET/CT og FDG PET/CT til præoperativ stadieinddeling af patienter med nydiagnosticeret Gynækologisk Kræftgynecological cancers:Vulvar cancerendometrial cancer (uterine cancer)cervical cancerovarian cancerMedDRA version: 20.0Level: LLTClassification code 10007107Term: Cancer of ovarySystem Organ Class: 100000021045MedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000020935MedDRA version: 20.0Level: LLTClassification code 10047743Term: Vulval cancer NOSSystem Organ Class: 100000021101MedDRA version: 20.0Level: LLTClassification code 10007063Term: Cancer of endometriumSystem Organ Class: 100000021008MedDRA version: 20.0Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000020977
EUCTR2016-004638-99-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET350
招募中
2 期
Phase II study of interim FDG-PET-guided response-adapted therapy in pediatric patients with Hodgkin's lymphoma (HL-14)s lymphomaHodgkin&#39
JPRN-UMIN000019093Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)50
进行中(未招募)
2 期
Phase II study of interim FDG-PET-guided response-adapted therapy in pediatric patients with Hodgkin's lymphoma (HL-14)
JPRN-jRCTs041180174Koga Yuhki50
尚未招募
1 期
Clearview-BC: A phase 1 Positron Emission Tomography (PET) - Computed Tomography (CT) study to evaluate the safety, biodistribution and pharmacokinetics of 89Zr-hu/mo-10D7 in patients with Bladder CancerMetastatic Bladder CancerCancer - Bladder
ACTRN12624000824561niversity of Queensland20